Back to discover
Disease

Miyoshi myopathy

Late-stage therapeutic development
Also known as MM, Miyoshi distal myopathy, Miyoshi muscular dystrophy, muscular dystrophy, distal, late onset, autosomal recessive+3 more

MM, Miyoshi distal myopathy, Miyoshi muscular dystrophy, muscular dystrophy, distal, late onset, autosomal recessive, MMD1, Miyoshi muscular dystrophy 1, Miyoshi muscular dystrophy type 1.

1
Clinical trials
12
Associated genes
4
Related proteins
Current focus
Calretinin biologyTherapeutic developmentInflammation & immunity

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

No activity recorded in this window. Try a wider timeframe.

Clinical trials

1 sponsors · 0 new · 0 completed in the last 12 months (net +0)

The current development programme across all trial phases.

Clinical programme
1
All trials
0
Active
1
Late-stage
1
Completed
Late-stage studies
Phase 2/3 · Completed · Ludwig-Maximilians - University of Munich
Recently completed
Phase 2/3 · Completed · Ludwig-Maximilians - University of Munich

Associated genes

12 matches

Genes associated with this disease in the canonical knowledge graph (Open Targets evidence). Number shows the association score.

Disease biology

4 matches

Proteins whose encoding gene is associated with this disease, reached through the canonical gene→disease graph. Number shows the gene's association score.

Reference

Authoritative identity, definition & identifiers.

Synonyms

MM, Miyoshi distal myopathy, Miyoshi muscular dystrophy, muscular dystrophy, distal, late onset, autosomal recessive, MMD1, Miyoshi muscular dystrophy 1, Miyoshi muscular dystrophy type 1

References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.